EH7-16124-55337
5 vaccinations
2 coded responses
15 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 900 / CA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Dose 1 — Pfizer-BioNTech
-
2021-03-08
Registered in v-safe
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-03-09
- 2021-03-10
- 2021-03-11
-
2021-03-28
Dose 2 — Pfizer-BioNTech
- 2021-03-29
- 2021-06-27
- 2021-09-26
-
2021-11-02
Dose 3 — Moderna
-
2022-03-28
Survey response — 12 months, dose 2MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: 5 weeks after getting a Moderna booster I experienced a flare of my autoimmune disease (undifferentiated connective tissue syndrome) which had been quiet for 8 years. I have been advised to double my hydroxychloroquine but flare not 100% gone · Healthcare visit (other): In-person visits with provider and blood workMedDRA releases: 2024-11 · check-in free text available
-
2022-03-28
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-29
-
2022-05-03
Survey response — 6 months, dose 3MedDRA: Condition aggravated, Inflammation, Office visit, Pre-existing disease, Pruritus — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Extreme inflammation and itching in my fingers. This is the same location where an underlying autoimmune disorder first flared 9 years ago that had been quiet until 5 weeks after I got a Moderna booster · Healthcare visit (other): In-person visits with dermatologist, rheumatologist and endocrinologistMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-04
- 2022-05-09
-
2022-05-09
Call successfulDoes not wish to fill out VAERS report
-
2022-05-09
Call successfulCompleted over the phone
-
2022-05-11
Dose 4 — Pfizer-BioNTech
- 2022-05-30
- 2022-06-01
- 2022-06-08
- 2022-06-16
- 2022-06-24
-
2022-09-19
Dose 5 — Pfizer-BioNTech
- 2023-05-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-03-28 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Moderna | No |
| 4 | 2022-05-11 | Pfizer-BioNTech | No |
| 5 | 2022-09-19 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 11 — 12 months, dose 2
Symptoms: 5 weeks after getting a Moderna booster I experienced a flare of my autoimmune disease (undifferentiated connective tissue syndrome) which had been quiet for 8 years. I have been advised to double my hydroxychloroquine but flare not 100% gone
Healthcare visit (other): In-person visits with provider and blood work
Release 11 — 6 months, dose 3
Symptoms: Extreme inflammation and itching in my fingers. This is the same location where an underlying autoimmune disorder first flared 9 years ago that had been quiet until 5 weeks after I got a Moderna booster
Healthcare visit (other): In-person visits with dermatologist, rheumatologist and endocrinologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release